Pharma Focus Asia

Target Market

Pharma Focus Asia provides the senior management with the direction they need to make the strategic decisions necessary to capture market share. Our readers represent the leading players in the Asian pharma market and the top global players-your target market. And our dedicated team of researchers ensure that the distribution list is unrivalled in its quality and reach. The readers of Pharma Focus Asia have requested to receive the publication because they recognise the value of its independent reporting. Taking a closer look at the quality of writing and the journalistic integrity, it clearly makes Pharma Focus Asia a powerful prospect for readers.

Business Segment

Pharma Focus Asia's circulation is spread across the following segments:

Biopharmaceuticals                                 Information Technology                 
BiotechnologyMachinery and Instruments
Bulk DrugsManufacturing
Clinical TrialsPackaging
ConsultingPharmaceuticals
Contract ResearchSpeciality Pharmaceuticals
GenericsVaccines
 

Geographical Distribution

Pharma Focus Asia is published quarterly with a paid circulation of over 5,500 hard book copies and an estimated readership of 90,000+ key decision makers globally. More than 90,000 readers receive e-book copies. This translates into an estimated readership base of over 180,000. (Source: Publisher's Survey)

Our readers represent the most important organisations in the Asian and global pharmaceutical market.

magazine-slider-image
magazine-slider-image
Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024